NFE2L2 and cancer: This dose- and context-dependent duality highlights DMF’s potential for both cancer prevention (via Nrf2 activation) and treatment (via Nrf2 inhibition in NRF2-dependent tumors), necessitating the development of tailored therapeutic strategies based on cancer type and genetic profile.